https://biotechmorning.com/news/pathos-ai-alphamab-astrazeneca-deals Biotech Morning en 2026-08-09T14:14:22.556Z Pathos AI Just Spent $2.2 Billion to Prove It's Not Just Another AI Hype Machine https://biotechmorning.com/news/tarsus-alkeus-800-million-stargardt-disease-deal Biotech Morning en 2026-08-09T14:13:36.321Z Tarsus Just Bet $800 Million on a Disease With Zero Treatments https://biotechmorning.com/news/circular-rna-in-vivo-car-t-ribox-fda-clearance Biotech Morning en 2026-08-09T14:12:52.925Z The CAR-T Hack That Skips the Factory Entirely https://biotechmorning.com/news/fda-casgevy-pediatric-sickle-cell-gene-therapy Biotech Morning en 2026-08-09T14:12:04.985Z A CRISPR Cure for Two-Year-Olds With Sickle Cell? The FDA Just Said Yes https://biotechmorning.com/news/intellia-crispr-liver-toxicity-root-cause Biotech Morning en 2026-08-09T14:11:19.467Z Intellia Says It Found the CRISPR Liver Toxicity Culprit. Now What? https://biotechmorning.com/news/lilly-ajax-jak-inhibitor-acquisition Biotech Morning en 2026-08-09T14:10:30.223Z Lilly Just Spent $2.3 Billion on a Drug Class With a Black Box Warning https://biotechmorning.com/news/argenx-forte-biosciences-acquisition-2-billion Biotech Morning en 2026-08-09T14:09:47.195Z argenx Just Dropped $2.2 Billion on a Company Most People Haven't Heard Of https://biotechmorning.com/news/lilly-kelonia-in-vivo-car-t-acquisition-2 Biotech Morning en 2026-08-09T14:09:00.311Z Lilly Just Dropped $7 Billion on a Cell Therapy That Skips the Factory https://biotechmorning.com/news/itc-investigation-china-biotech-subsidies Biotech Morning en 2026-08-09T14:08:13.451Z Uncle Sam Just Opened a File on China's Biotech Playbook https://biotechmorning.com/news/car-t-prevent-multiple-myeloma Biotech Morning en 2026-08-08T14:14:08.483Z What If You Could Kill Cancer Before It Even Starts? https://biotechmorning.com/news/gene-editor-delete-hepatitis-b Biotech Morning en 2026-08-08T14:13:23.426Z The Gene Editor That Might Actually Delete Hepatitis B https://biotechmorning.com/news/nih-visa-researchers-funding-blocked Biotech Morning en 2026-08-08T14:12:34.073Z NIH Is About to Slam the Door on Thousands of Foreign Scientists https://biotechmorning.com/news/biomarin-bmn-401-phase-3-failure-270-million Biotech Morning en 2026-08-08T14:11:50.029Z BioMarin Just Torched $270 Million on a Drug That Couldn't Deliver https://biotechmorning.com/news/merck-tulisokibart-split-phase-2-results Biotech Morning en 2026-08-08T14:11:07.709Z Merck's Drug Aced One Test and Bombed the Other. That Tells Us a Lot. https://biotechmorning.com/news/fda-moderna-flu-vaccine-rejection-vaccine-industry-impact Biotech Morning en 2026-08-08T14:10:21.709Z The FDA Just Picked a Fight With Moderna's Flu Shot. The Whole Vaccine Industry Is Watching. https://biotechmorning.com/news/melanoma-drug-fda-rejected-twice-approved Biotech Morning en 2026-08-08T14:09:37.527Z The Melanoma Drug the FDA Rejected Twice Just Got Approved https://biotechmorning.com/news/crispr-worst-nightmare-intellia-clinical-hold Biotech Morning en 2026-08-08T14:08:43.813Z CRISPR's Worst Nightmare Just Became Real